Optimum low dose CT screening interval for lung cancer: The answer from NELSON?

Thorax

Volumn 72, Issue 1, 2017, Pages 6-7

  Baldwin, David R ^a   Duffy, S W ^b   Devaraj, A ^e   Field, J K ^c,d  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e NONE

Author keywords

Imaging CT MRI etc; Lung Cancer

Indexed keywords

AGE DISTRIBUTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LOW ENERGY RADIATION; LUNG CANCER; LUNG NODULE; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; UNITED KINGDOM; UNITED STATES; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84994494470     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209011     Document Type: Editorial

References (13)

1. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
2. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907-16.
3. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5 years screening interval. Thorax 2017;72:48-56.
4. Field JK, Hansell DM, Duffy SW, et al. CT screening for lung cancer: countdown to implementation. Lancet Oncol 2013;14:e591-600.
5. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311-20.
6. Sverzellati N, Silva M, Calareso G, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol 2016;26:3821-9.
7. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159:411-20.
8. Lewin G, Morissette K, Dickinson J, et al., Canadian Task Force on Preventive Health Care. Recommendations on screening for lung cancer. CMAJ 2016;188:425-32.
9. Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161-70.
10. Breast Cancer Screening. http://www.nhs.uk/Conditions/breast-cancer-screening/Pages/When-its-offered.aspx-family-history
11. Aberle DR, Adams AM, Berg CD, et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
12. Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764.
13. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.